NEOG EBITDA | Neogen Corporation

Neogen Corporation (NEOG) EBITDA

2026-05-31: Basis Reported; EBITDA $32.5M; Operating income (m); Depreciation and amortization (m).
2026-02-28: Basis Reported; EBITDA $25.62M*; Operating income -$3.30M; Depreciation and amortization $28.92M*.
2025-11-30: Basis Reported; EBITDA $23.55M*; Operating income -$5.38M; Depreciation and amortization $28.93M*.
2025-08-31: Basis Reported; EBITDA $12.96M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2010-05-31 to 2026-05-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-05-31	Reported	$32.5M	(m)	(m)	(m)	14.43%	(m)	(m)	(m)	(m)	(m)	(m)
2026-02-28	Reported	$25.62M*	-$3.30M	$28.92M*	$211.20M	12.13%*	(m)	$22.70M*	$112.20M	$3.80M	(m)	-$3.30M
2025-11-30	Reported	$23.55M*	-$5.38M	$28.93M*	$224.69M	10.48%*	(m)	$19.44M*	$118.01M	$4.56M	(m)	-$4.44M
2025-08-31	Reported	$12.96M	(m)	(m)	(m)	6.20%	(m)	$10.85M	$114.22M	$5.13M	(m)	$7.47M
2025-05-31	Reported	-$580.9M	(m)	(m)	(m)	-257.61%	(m)	(m)	(m)	(m)	(m)	(m)
2025-02-28	Reported	$34.75M*	$5.40M	$29.35M*	$221.00M	15.72%*	(m)	$19.46M*	$110.70M	$4.50M	(m)	$1.20M
2024-11-30	Reported	-$427.44M*	-$457.48M	$30.05M*	$231.26M	-184.83%*	(m)	$40.25M*	$117.93M	$5.11M	(m)	-$20.29M
2024-08-31	Reported	$32.06M	(m)	(m)	(m)	14.78%	(m)	-$17.91M	$112.04M	$5.20M	(m)	-$3.00M
2024-05-31	Reported	$41.82M	(m)	(m)	(m)	17.66%	(m)	(m)	(m)	(m)	(m)	(m)
2024-02-29	Reported	$41.67M*	$12.02M	$29.65M*	$228.81M	18.21%*	(m)	-$30.21M*	$111.93M	$4.85M	(m)	-$3.80M
2023-11-30	Reported	$43.93M*	$14.46M	$29.47M*	$229.63M	19.13%*	(m)	$15.71M*	$112.86M	$5.76M	(m)	-$260.00K
2023-08-31	Reported	$47.87M	(m)	(m)	(m)	20.90%	(m)	$23.01M	$112.23M	$6.72M	(m)	$160.00K
2023-05-31	Reported	$51.86M	(m)	(m)	(m)	21.45%	(m)	(m)	(m)	(m)	(m)	(m)
2023-02-28	Reported	$43.16M*	$15.68M	$27.47M*	$218.25M	19.77%*	(m)	-$17.07M*	$110.29M	$7.26M	(m)	-$10.45M
2022-11-30	Reported	$19.08M*	-$7.66M	$26.74M*	$230.03M	8.30%*	(m)	-$18.73M*	$117.49M	$6.85M	(m)	$7.75M
2022-08-31	Reported	$11.79M	(m)	(m)	(m)	8.91%	(m)	-$14.14M	$70.08M	$4.88M	(m)	$1.45M
2022-05-31	Reported	$23.89M	(m)	(m)	(m)	17.05%	(m)	(m)	(m)	(m)	(m)	(m)
2022-02-28	Reported	$12.70M*	$6.38M	$6.32M*	$128.24M	9.90%*	(m)	$6.59M*	$70.83M	$4.56M	(m)	$1.20M
2021-11-30	Reported	$18.30M*	$12.47M	$5.83M*	$130.52M	14.02%*	(m)	$17.85M*	$69.92M	$4.33M	(m)	$2.10M
2021-08-31	Reported	$27.43M	(m)	(m)	(m)	21.38%	(m)	$23.21M	$68.30M	$4.33M	(m)	$4.65M
2021-05-31	Reported	$26.19M	(m)	(m)	(m)	20.55%	(m)	(m)	(m)	(m)	(m)	(m)
2021-02-28	Reported	$21.36M*	$15.77M	$5.58M*	$116.71M	18.30%*	(m)	$11.60M*	$62.86M	$4.24M	(m)	$2.60M
2020-11-30	Reported	$24.05M*	$19.25M	$4.80M*	$115.00M	20.91%*	(m)	$22.39M*	$61.79M	$4.06M	(m)	$3.45M
2020-08-31	Reported	$23.62M	(m)	(m)	(m)	21.60%	(m)	$25.13M	$59.02M	$3.88M	(m)	$3.95M
2020-05-31	Reported	$24.8M	(m)	(m)	(m)	22.74%	(m)	(m)	(m)	(m)	(m)	(m)
2020-02-29	Reported	$17.60M*	$13.04M	$4.56M*	$99.87M	17.62%*	(m)	$19.78M*	$54.54M	$3.82M	(m)	$2.05M
2019-11-30	Reported	$22.82M*	$18.27M	$4.55M*	$107.80M	21.17%*	(m)	$16.75M*	$56.78M	$3.78M	(m)	$2.95M
2019-08-31	Reported	$20.7M	(m)	(m)	(m)	20.41%	(m)	$23.72M	$53.23M	$3.69M	(m)	$3.00M
2019-05-31	Reported	$23.33M	(m)	(m)	(m)	21.25%	(m)	(m)	(m)	(m)	(m)	(m)
2019-02-28	Reported	$19.07M*	$14.64M	$4.43M*	$97.70M	19.52%*	(m)	$10.38M*	$53.07M	$3.25M	(m)	$3.55M
2018-11-30	Reported	$22.57M*	$18.25M	$4.33M*	$107.10M	21.08%*	(m)	$16.50M*	$57.06M	$3.17M	(m)	$3.65M
2018-11-30	Reported	(m)	$18.25M	(m)	$107.10M	(m)	(m)	(m)	$57.06M	$3.17M	(m)	$3.65M
2018-08-31	Reported	$20.75M	(m)	(m)	(m)	20.83%	(m)	$16.08M	$52.90M	$2.82M	(m)	$1.90M
2018-05-31	Reported	$24.24M	(m)	(m)	(m)	22.42%	(m)	(m)	(m)	(m)	(m)	(m)
2018-02-28	Reported	$20.33M*	$15.91M	$4.41M*	$94.90M	21.42%*	(m)	$19.17M*	$50.30M	$2.84M	(m)	$700.00K
2017-11-30	Reported	$22.27M*	$18.00M	$4.28M*	$100.67M	22.13%*	(m)	$8.74M*	$52.45M	$2.97M*	(m)	$1.90M*
2017-11-30	Reported	(m)	$18.00M	(m)	$100.70M	(m)	(m)	(m)	$52.45M	$2.97M	(m)	$1.90M
2017-08-31	Reported	$20.42M	(m)	(m)	(m)	21.67%	(m)	$18.67M	$49.28M	$3.10M	(m)	$5.30M
2017-05-31	Reported	$23M	(m)	(m)	(m)	24.08%	(m)	(m)	(m)	(m)	(m)	(m)
2017-02-28	Reported	(m)	$14.35M	(m)	(m)	(m)	(m)	(m)	(m)	$2.64M	(m)	$5.35M
2016-11-30	Reported	$20.41M*	$16.85M	$3.56M*	(m)	(m)	(m)	(m)	(m)	$2.77M	(m)	$5.60M
2016-08-31	Reported	$18.22M	(m)	(m)	(m)	21.78%	(m)	(m)	(m)	$2.68M	(m)	$5.30M
2016-05-31	Reported	$18.98M	(m)	(m)	(m)	21.07%	(m)	(m)	(m)	(m)	(m)	(m)
2016-02-29	Reported	(m)	$11.25M	(m)	(m)	(m)	(m)	(m)	(m)	$2.45M	(m)	$3.35M
2015-11-30	Reported	(m)	$14.61M	(m)	(m)	(m)	(m)	(m)	(m)	$2.62M	(m)	$5.05M
2015-08-31	Reported	$17.6M	(m)	(m)	(m)	23.51%	(m)	(m)	(m)	(m)	(m)	(m)
2015-05-31	Reported	$17.42M	(m)	(m)	(m)	22.16%	(m)	(m)	(m)	(m)	(m)	(m)
2015-02-28	Reported	(m)	$12.16M	(m)	(m)	(m)	(m)	(m)	(m)	$2.37M	(m)	$4.22M
2014-11-30	Reported	$15.55M*	$12.90M	$2.65M*	(m)	(m)	(m)	(m)	(m)	$2.47M	(m)	$4.60M
2014-08-31	Reported	$15.95M	(m)	(m)	(m)	23.60%	(m)	(m)	(m)	$2.40M	(m)	$4.80M
2014-05-31	Reported	$13.53M	(m)	(m)	(m)	20.12%	(m)	(m)	(m)	(m)	(m)	(m)
2014-02-28	Reported	$12.76M*	$10.29M	$2.47M*	(m)	(m)	(m)	$6.43M*	(m)	$2.11M	(m)	$3.70M
2013-11-30	Reported	$11.83M*	$9.69M	$2.14M*	(m)	(m)	(m)	$5.22M*	(m)	$2.30M	(m)	$3.50M
2013-08-31	Reported	$14.45M	(m)	(m)	(m)	24.68%	(m)	$5.51M	(m)	$2.09M	(m)	$4.20M
2013-05-31	Reported	$12.38M	(m)	(m)	(m)	22.10%	(m)	(m)	(m)	(m)	(m)	(m)
2013-02-28	Reported	$11.65M*	$9.67M	$1.98M*	(m)	(m)	(m)	$8.55M*	(m)	$1.98M	(m)	$3.45M
2012-11-30	Reported	$12.14M*	$10.48M	$1.67M*	(m)	(m)	(m)	$6.89M*	(m)	$1.99M	(m)	$3.80M
2012-08-31	Reported	$11.95M	(m)	(m)	(m)	24.04%	(m)	$4.44M	(m)	$1.93M	(m)	$3.70M
2012-05-31	Reported	$10.38M	(m)	(m)	(m)	21.38%	(m)	(m)	(m)	(m)	(m)	(m)
2012-02-29	Reported	$9.13M*	$7.55M	$1.58M*	(m)	(m)	(m)	$7.06M*	(m)	$1.75M	(m)	$2.90M
2011-11-30	Reported	$9.68M*	$8.14M	$1.53M*	(m)	(m)	(m)	$4.83M*	(m)	$1.71M	(m)	$2.90M
2011-08-31	Reported	$10.73M	(m)	(m)	(m)	23.48%	(m)	$1.35M	(m)	$1.51M	(m)	$3.30M
2011-05-31	Reported	$9.93M	(m)	(m)	(m)	22.78%	(m)	(m)	(m)	(m)	(m)	(m)
2011-02-28	Reported	$9.42M*	$8.06M	$1.36M*	(m)	(m)	(m)	$4.40M*	(m)	$1.80M	(m)	$2.90M
2010-11-30	Reported	$10.95M*	$9.63M	$1.32M*	(m)	(m)	(m)	$8.01M*	(m)	$1.64M	(m)	$3.40M
2010-08-31	Reported	$10.86M	(m)	(m)	(m)	25.29%	(m)	$11.55M	(m)	$1.80M	(m)	$3.40M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-05-31	Reported	$94.7M	(m)	(m)	(m)	10.88%	(m)	$83.20M	$461.90M	$18.40M	(m)	-$1.10M
2025-05-31	Reported	-$941.5M	(m)	(m)	(m)	-105.23%	(m)	$58.20M	$473.30M	$21.10M	(m)	-$41.10M
2024-05-31	Reported	$175.3M	(m)	(m)	(m)	18.97%	(m)	$35.30M	$460.30M	$22.50M	(m)	-$4.90M
2023-05-31	Reported	$125.89M	(m)	(m)	(m)	15.31%	(m)	$41.03M	$416.49M	$26.04M	(m)	$828.00K
2022-05-31	Reported	$82.31M	(m)	(m)	(m)	15.61%	(m)	$68.04M	$284.15M	$17.05M	(m)	$11.90M
2021-05-31	Reported	$95.21M	(m)	(m)	(m)	20.32%	(m)	$81.09M	$253.40M	$16.25M	(m)	$14.39M
2020-05-31	Reported	$85.92M	(m)	(m)	(m)	20.55%	(m)	$85.88M	$221.89M	$14.75M	(m)	$12.83M
2019-05-31	Reported	$85.72M	(m)	(m)	(m)	20.70%	(m)	$63.84M	$222.27M	$12.80M	(m)	$12.78M
2018-05-31	Reported	$87.25M	(m)	(m)	(m)	21.93%	(m)	$69.13M	$211.66M	$10.86M	(m)	$10.25M
2017-05-31	Reported	$79.64M	(m)	(m)	(m)	22.23%	(m)	$60.27M	$189.35M	$10.38M	(m)	$22.70M
2016-05-31	Reported	$68.57M	(m)	(m)	(m)	21.34%	(m)	$35.33M	$168.21M	$9.89M	(m)	$18.98M
2015-05-31	Reported	$63.77M	(m)	(m)	(m)	22.53%	(m)	(m)	(m)	$9.58M	(m)	$18.50M
2014-05-31	Reported	$52.57M	(m)	(m)	(m)	21.25%	(m)	$21.67M	(m)	$8.33M	(m)	$15.00M
2013-05-31	Reported	$48.12M	(m)	(m)	(m)	23.19%	(m)	$26.56M	(m)	$7.78M	(m)	$14.10M
2012-05-31	Reported	$39.91M	(m)	(m)	(m)	21.69%	$1.50M	$22.28M	(m)	$6.64M	(m)	$11.45M
2011-05-31	Reported	$41.16M	(m)	(m)	(m)	23.84%	(m)	$28.84M	(m)	$6.83M	(m)	$12.40M
2010-05-31	Reported	$31.31M	(m)	(m)	(m)	22.29%	(m)	$27.99M	(m)	$6.26M	(m)	$9.80M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Celldex Therapeutics, Inc. (CLDX)	United States	$2.471B	-9.72
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)	United States	$0.806B	-5.88
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Insight Molecular Diagnostics Inc. (IMDX)	United States	$0.129B	-3.90
IMMUCELL CORP /DE/ (ICCC)	United States	$0.091B	116.10
BIOMERICA INC (BMRA)	United States	$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)	United States	$0.008B	-1.93